ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives $3.30 Consensus Price Target from Analysts
Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month […]
Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month […]
